Stanley Lipkowitz, MD
Enriched profileDeputy Director, Center for Cancer Research (NCI) · National Cancer Institute
Stanley Lipkowitz is Deputy Director, Center for Cancer Research (NCI) at National Cancer Institute. OpenAlex indexes 372 publications with 8,539 citations (h-index 43); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.
Data verified 27 Oct 2026
Overview
Updated 28 Oct 2026
Stanley Lipkowitz, MD, PHD, is Deputy Director, Center for Cancer Research (NCI) at National Cancer Institute. The public record shows 372 publications with 8,539 citations (h-index 43), centered on Cancer Immunotherapy and Biomarkers, Breast Cancer Treatment Studies, Cancer Cells and Metastasis. It also documents an investigator role on 5 registered clinical trials.
- Most recent indexed publication: 2026 · Molecular cancer therapeutics
- Top research focus: Cancer Immunotherapy and Biomarkers
- 5 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 28 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 26 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 92.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 28 Oct 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
Sponsor: National Cancer Institute (NCI)
- ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma
Sponsor: National Cancer Institute (NCI)
- T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery
Sponsor: National Cancer Institute (NCI)
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 28 Oct 2026
36 congress contributions (2004–2026) across AACR, ASCO, ESMO per OpenAlex. The most recent:
- Abstract LB056: Inhibiting WEE1 kinase enhances sensitivity of high grade serous ovarian cancer cells to the novel KIF18A inhibitor ATX020
AACR Annual Meeting
AACR2026Co-authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 28 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Preclinical modeling of trastuzumab deruxtecan in a mouse model of brain metastatic triple-negative breast cancer identifies two contributors to efficacy.
Molecular cancer therapeutics
Article2026
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.Article552 citations1999
- 04
Network
Updated 28 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 28 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/stanley-lipkowitz-md
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
irp.nih.gov/blog/post/2019/10/irp-breast-cancer-researchers-answer-redditor-questions
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →irp.nih.gov ↗ - Other
cancer.gov/types/breast/research/experts-discuss-challenges-breast-cancer-research-video
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.gov ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 28 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD and PhD
Weill Cornell Medical College
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →wcpinst.org ↗
Secondary affiliations
appointments beyond the home institution- Attending clinician
NCI Intramural Oncology Service
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →wcpinst.org ↗ - Breast Cancer Clinic
Murtha Cancer Center at Walter Reed National Military Medical Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →wcpinst.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →irp.nih.gov ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Kevin Brown, MD
National Cancer Institute
Gregory Reaman, MD
National Cancer Institute
James Gulley, MD
National Cancer Institute
Robert Kreitman, MD
National Cancer Institute
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Eric Winer, MD
Yale School of Medicine
Norman Wolmark, MD
University of Pittsburgh
Hope Rugo, MD
City of Hope